Overview

Pharmacokinetic Study of Pediatric Subjects With Tinea Cruris and Tinea Pedis

Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
This study is being done to see how the body is affected when a study drug is applied to both feet if the subject has athlete's foot or to both feet and the groin area if the subject has both athlete's foot and jock itch. Safety of the drug and how well the drug works will also be measured.
Phase:
Phase 4
Details
Lead Sponsor:
Merz North America, Inc.
Merz Pharmaceuticals, LLC
Treatments:
Naftifine